NEW YORK (GenomeWeb News) – Abbott's board of directors this week approved the separation of the firm's research-based pharmaceuticals business into a new company called AbbVie and declared a special dividend distribution for all of the outstanding shares of AbbVie common stock.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.